Knowledge Base Retrieval and Recall for mRNA Vaccine Clinical Trial Pre-screening

Data for mRNA vaccine clinical trial pre-screening primarily comes from global clinical trial registries (e.g., ClinicalTrials.gov, WHO ICTRP)

Data Characteristics

Data for mRNA vaccine clinical trial pre-screening primarily comes from global clinical trial registries (e.g., ClinicalTrials.gov, WHO ICTRP), regulatory approval documents (e.g., FDA, EMA review reports), preclinical and clinical research papers in academic journals, and public R&D pipeline information from pharmaceutical companies. This data updates frequently, especially during Phase III clinical trials, where updates may occur weekly. Document structures vary, including structured trial protocol summaries, unstructured full research reports, and semi-structured tabular data (e.g., subject baseline characteristics, adverse event lists). Key fields include trial ID, sponsor, investigational drug, indication, inclusion/exclusion criteria, primary/secondary endpoints, dosage, administration route, number of subjects, and geographic region. Units commonly used are micrograms (μg) or milligrams (mg) for dosage, days (days) or weeks (weeks) for time periods, and concentration (ng/mL) or percentage (%) for biomarkers.

Constraints on Knowledge Base Retrieval and Recall

High-frequency data updates require the knowledge base to support real-time, incremental updates and fast indexing. Diverse document structures necessitate flexible text parsing strategies to handle variations from structured summaries to unstructured full text, ensuring accurate extraction of key information. For example, critical information like inclusion/exclusion criteria may appear as long text paragraphs, requiring fine-grained segmentation strategies. Field and unit specificity demands that the retrieval mechanism recognizes and matches these specialized terms, preventing information loss or misinterpretation due to inconsistent units. Furthermore, subject population definitions in trial protocols often involve multiple conditions, requiring the recall mechanism to handle complex logical combination queries. If answers are long, such as lengthy research reports, consider how to efficiently extract the most relevant part to the user's question, avoiding redundant information.

Configuration Settings

Configuration ItemSuggested ValueRationale
Chunk Length800–1200 charactersAccommodates long sentences and complex paragraphs in clinical research reports while balancing information completeness and model processing capacity
Overlap Length100–200 charactersEnsures continuity of information across chunks and captures contextual associations
Recall CountTop 5Balances recall breadth with model processing efficiency, focusing on the most relevant results
Similarity ThresholdCalibrate based on actual measurementsAdjust according to specific datasets and query types to ensure relevance of recalled results
Rerank Return CountTop 3Further refines recalled results, improving the accuracy and conciseness of the final answer
Parsing StrategySmart chunking, with table recognitionAddresses document types containing both unstructured text and semi-structured tables

Common Pitfalls

  • Recall results contain many irrelevant trials because the similarity threshold is set too low, returning results even for non-core keyword matches.
  • AI answers are interrupted or incomplete because knowledge base chunks are too long, and the single recall content exceeds the model's max_tokens limit.
  • Specific dosage trials cannot be accurately retrieved because numbers and units are not distinguished during parsing, treating "5mg" and "5μg" as identical.

How to Verify Configuration

  • For typical queries (e.g., "inclusion and exclusion criteria for a specific mRNA vaccine in Phase III clinical trials for individuals aged 18-65"), check if recall results include all relevant clinical trial IDs and key inclusion/exclusion criteria text.
  • Use queries of varying lengths and complexity to verify the completeness and fluency of AI answers, ensuring no interruptions due to excessively long knowledge base content.
  • Enter queries containing specialized terms and units (e.g., "adverse events in the 50μg dose group") to confirm that recall results precisely match data with specific units.
  • Regularly track recall effectiveness after knowledge base updates to ensure new data is retrieved promptly and utilized effectively.

The values provided are common starting points. Measure them against your own samples.

Question material comes from public community discussions. Configuration values are common starting points and should be measured against your own samples. Verified on 2026-09-21.